V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10224890 | 10063777 | 0 | 92 | null | 2021-08-03 | 2021-10-13 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101393141 |
| 10226421 | 10063782 | 1.58 | 0 | Palliative (P) | 2017-04-10 | 2017-05-30 | Avelumab | 02 | N | TRASTUZUMAB | 100456390 |
| 10226635 | 10063783 | 1.75 | null | null | 2021-05-30 | 2021-06-14 | Avelumab | 02 | null | DARATUMUMAB | 101668852 |
| 10226763 | 10063784 | 1.62 | 45.8 | Adjuvant (A) | 2021-12-19 | 2021-12-20 | Avelumab | 02 | N | CAPECITABINE + OXALIPLATIN | 101141825 |
| 10226863 | 10063785 | 1.71 | 90 | null | 2020-03-26 | 2020-03-26 | Avelumab | null | N | CAPECITABINE + OXALIPLATIN | 101573223 |
| 10227001 | 10063786 | 1.7 | 88.1 | Adjuvant (A) | null | 2019-11-24 | Avelumab | 02 | null | AVELUMAB | 100796805 |
| 10227651 | 10063788 | 1.86 | 0 | Curative (C) | 2019-12-23 | 2020-01-17 | Oxaliplatin + Modified de Gramont | 02 | N | FLUOROURACIL + OXALIPLATIN | 101690601 |
| 10230784 | 10063793 | 1.62 | 73.7 | null | null | 2020-11-18 | Avelumab | 02 | null | DARATUMUMAB | 101146406 |
| 10231140 | 10063794 | 1.58 | 87.6 | 03 | 2019-11-23 | 2019-12-02 | Avelumab | 02 | N | DARATUMUMAB | 101053845 |
| 10231374 | 10063795 | 1.79 | 82 | Palliative (P) | 2021-03-17 | 2021-03-31 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101483888 |
| 10231376 | 10063796 | 1.63 | 55.9 | null | 2019-07-10 | 2019-08-27 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100676160 |
| 10231545 | 10063797 | 1.69 | 67.4 | null | 2019-06-25 | 2019-06-25 | Bendamustine+Rituximab (1st Course) | 02 | null | BENDAMUSTINE + RITUXIMAB | 101284356 |
| 10232064 | 10063798 | 1.56 | 58.7 | null | 2019-05-17 | 2019-05-17 | BENDAMUSTINE + RITUXIMAB | 02 | null | BENDAMUSTINE + RITUXIMAB | 101865721 |
| 10232178 | 10063799 | null | 75.9 | null | 2018-03-28 | 2018-04-23 | FLUOROURACIL + OXALIPLATIN | null | null | FLUOROURACIL + OXALIPLATIN | 101522131 |
| 10233194 | 10063802 | 1.77 | 71.9 | Palliative (P) | 2019-02-15 | 2019-03-29 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100233809 |
| 10233331 | 10063803 | 1.68 | 61 | null | 2020-08-27 | 2020-11-06 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100238921 |
| 10233458 | 10063804 | 1.88 | 73.9 | null | 2019-09-18 | 2019-10-31 | Avelumab | N | null | FLUOROURACIL + OXALIPLATIN | 100974719 |
| 10233680 | 10063805 | 1.76 | 62.8 | Palliative (P) | 2018-06-04 | 2019-08-18 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100366842 |
| 10233986 | 10063807 | 1.81 | 114.8 | null | 2018-11-27 | 2018-11-27 | Venetoclax | 02 | null | VENETOCLAX | 101462192 |
| 10234571 | 10063809 | 1.55 | 85.8 | Palliative (P) | 2018-04-12 | 2018-04-12 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100375918 |
| 10234725 | 10063810 | 1.66 | 62.2 | Neo-adjuvant (N) | 2019-09-07 | 2019-09-11 | Avelumab | 02 | N | AVELUMAB | 100586677 |
| 10234822 | 10063811 | 1.59 | 53 | null | 2021-11-20 | 2022-03-25 | Trastuzumab | 02 | null | AVELUMAB | 100229423 |
| 10235116 | 10063812 | 0 | 74 | null | 2018-10-03 | 2019-03-27 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100766020 |
| 10236147 | 10063813 | 1.74 | 80.3 | null | 2019-11-12 | 2019-11-15 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100387980 |
| 10236447 | 10063814 | 1.7 | 66.2 | Disease modification (D) | null | 2021-10-31 | DARATUMUMAB | 02 | N | DARATUMUMAB | 100303527 |
| 10236514 | 10063815 | 1.64 | 85 | null | 2022-03-25 | 2022-03-25 | Venetoclax | 02 | null | VENETOCLAX | 101451366 |
| 10236529 | 10063816 | 1.85 | 44.6 | Palliative (P) | 2018-10-24 | 2018-10-25 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 100113486 |
| 10236538 | 10063817 | 1.68 | 79 | Palliative (P) | 2018-08-18 | 2018-09-13 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101480177 |
| 10237132 | 10063819 | 1.83 | 56 | null | 2021-04-26 | 2021-05-10 | Bendamustine+Rituximab(Sub Courses) | 02 | null | BENDAMUSTINE + RITUXIMAB | 100214524 |
| 10237448 | 10063821 | 1.76 | 56.7 | null | 2022-03-30 | 2022-04-14 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101269446 |
| 10237576 | 10063822 | 1.78 | 84.8 | null | 2020-03-09 | 2021-07-15 | FLUOROURACIL + OXALIPLATIN | 02 | null | FLUOROURACIL + OXALIPLATIN | 100025985 |
| 10240641 | 10063828 | 1.6 | 57.75 | null | 2014-06-12 | 2021-06-21 | DARATUMUMAB | 02 | null | CAPECITABINE + OXALIPLATIN | 101087869 |
| 10240691 | 10063829 | null | 60 | null | 2020-02-14 | 2020-09-04 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 101107602 |
| 10240774 | 10063831 | 1.84 | 61.3 | null | 2020-08-18 | 2020-08-18 | Venetoclax | 02 | null | VENETOCLAX | 101764531 |
| 10240827 | 10063833 | 1.62 | 57.2 | null | null | 2022-03-30 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101487122 |
| 10241321 | 10063834 | 1.71 | 71.25 | null | 2021-01-02 | 2021-01-02 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100499415 |
| 10241432 | 10063835 | 1.83 | 56.8 | null | 2020-07-15 | 2020-07-20 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100578405 |
| 10241543 | 10063836 | 0 | 85.7 | null | 2020-09-05 | 2020-10-09 | Avelumab | 02 | null | TRASTUZUMAB | 100279137 |
| 10243135 | 10063840 | 1.57 | 75 | null | 2019-05-26 | 2019-06-05 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100893985 |
| 10243149 | 10063841 | 1.75 | 62.3 | null | 2017-02-26 | 2017-02-26 | Venetoclax | N | null | VENETOCLAX | 100621325 |
| 10243387 | 10063843 | 1.83 | 45.8 | Curative (C) | 2017-09-29 | 2018-07-26 | Avelumab | 02 | N | AVELUMAB | 101039700 |
| 10243418 | 10063844 | 1.86 | 72.8 | Palliative (P) | 2019-03-24 | 2019-03-25 | DARATUMUMAB | 02 | N | DARATUMUMAB | 101309108 |
| 10243593 | 10063845 | 1.71 | 73.4 | 03 | 2019-05-28 | 2019-05-29 | DARATUMUMAB | 02 | N | DARATUMUMAB | 101514639 |
| 10243595 | 10063846 | 1.82 | 79.5 | Palliative (P) | 2018-11-10 | 2018-11-23 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100696389 |
| 10243762 | 10063849 | 1.74 | null | Palliative (P) | 2021-11-25 | 2021-12-11 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101135586 |
| 10243770 | 10063850 | 1.63 | 42 | null | 2018-12-05 | 2018-12-18 | Avelumab | null | null | VENETOCLAX | 100381694 |
| 10244287 | 10063852 | 1.68 | 72 | null | 2022-03-02 | 2022-03-03 | Venetoclax | 02 | null | VENETOCLAX | 100123745 |
| 10244582 | 10063855 | 1.68 | 81 | null | 2018-08-09 | 2018-08-19 | Bendamustine+Rituximab(Sub Courses) | N | null | NIVOLUMAB | 101155893 |
| 10244607 | 10063856 | 1.88 | 59.95 | null | 2021-02-26 | 2021-03-13 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100231600 |
| 10244630 | 10063857 | 1.68 | 69 | null | 2017-10-02 | 2017-12-04 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 100705712 |